Quidel Corporation (QDEL): Price and Financial Metrics

Quidel Corporation (QDEL): $42.40

0.55 (+1.31%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

QDEL Price/Volume Stats

Current price $42.40 52-week high $89.11
Prev. close $41.85 52-week low $37.78
Day low $41.26 Volume 796,800
Day high $42.50 Avg. volume 1,007,454
50-day MA $43.18 Dividend yield N/A
200-day MA $61.19 Market Cap 2.84B

QDEL Stock Price Chart Interactive Chart >


Quidel Corporation (QDEL) Company Bio


Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications primarily in infectious diseases, women’s health, and gastrointestinal diseases. The company was founded in 1979 and is based in San Diego, California.


QDEL Latest News Stream


Event/Time News Detail
Loading, please wait...

QDEL Latest Social Stream


Loading social stream, please wait...

View Full QDEL Social Stream

Latest QDEL News From Around the Web

Below are the latest news stories about QUIDELORTHO CORP that investors may wish to consider to help them evaluate QDEL as an investment opportunity.

Investors in QuidelOrtho (NASDAQ:QDEL) have unfortunately lost 59% over the last three years

Investing in stocks inevitably means buying into some companies that perform poorly. But the long term shareholders of...

Yahoo | December 26, 2023

QuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare Conference

SAN DIEGO, December 22, 2023--QuidelOrtho Corporation (NASDAQ:QDEL) ("QuidelOrtho"), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced that Douglas Bryant, President and Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024, in San Francisco, CA, scheduled for 12:00 p.m. ET / 9:00 a.m. PT.

Yahoo | December 22, 2023

QuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR Assay

SAN DIEGO, December 20, 2023--QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, has received 510(K) clearance from the U.S. Food and Drug Administration for its innovative Savanna PCR platform and Savanna HSV 1+2/VZV in vitro diagnostic test for the detection and differentiation of Herpes simplex virus type 1 (HSV-1), Herpes simplex virus type 2 (HSV

Yahoo | December 20, 2023

Why is QuidelOrtho (QDEL) a Good Stock to Invest in?

ClearBridge Investments, an investment management company, released its “ClearBridge All Cap Value Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. The strategy outperformed the benchmark, the Russell 3000 Value Index, in the third quarter. Favorable stock selection in the consumer discretionary, healthcare, and utilities sectors, as well as an […]

Yahoo | December 13, 2023

QuidelOrtho to Participate in the Evercore ISI Conference

SAN DIEGO, November 16, 2023--QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team are scheduled to participate in the Evercore ISI conference in Miami, FL, on November 30, 2023.

Yahoo | November 16, 2023

Read More 'QDEL' Stories Here

QDEL Price Returns

1-mo 6.96%
3-mo -7.56%
6-mo -38.62%
1-year -50.43%
3-year -65.10%
5-year -23.23%
YTD -42.47%
2023 -13.97%
2022 -36.54%
2021 -24.86%
2020 139.44%
2019 53.69%

Continue Researching QDEL

Here are a few links from around the web to help you further your research on Quidel Corp's stock as an investment opportunity:

Quidel Corp (QDEL) Stock Price | Nasdaq
Quidel Corp (QDEL) Stock Quote, History and News - Yahoo Finance
Quidel Corp (QDEL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!